Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Isabell

17 indexed publications match this author name.

ORCID: 0009-0008-2952-586X
OpenAlex: https://openalex.org/A5069070940

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Depression 8 Pharmacology 7 Anxiety 6 Clinical Trial 6 Healthy Volunteers 5 Addiction 5 Safety 5 Microdosing 4 Review Article 4 Consciousness 3 Receptor Pharmacology 3 Systematic Review 3

Journals

Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 2 Neuropsychopharmacology 1 European Journal of Neuroscience 1 Religion Brain & Behavior 1 Open Access CRIS of the University of Bern 1 JAMA network open 1 bioRxiv 1 Psychotherapy (Chicago, Ill.) 1

Publication history

Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participantsNeuropsychopharmacology · 2026-07-01 Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal CortexEuropean Journal of Neuroscience · 2026-06-01 Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-31 Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.Open Access CRIS of the University of Bern · 2026-01-21 Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.JAMA network open · 2026-01-02 Psilocybin decreases reward-seeking behavior accompanied by increased activity of parvalbumin neurons with perineuronal nets in the medial prefrontal cortexbioRxiv · 2025-12-26 A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.Psychotherapy (Chicago, Ill.) · 2025-09-01 Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.Clinical pharmacology and therapeutics · 2025-06-01 166. Dynamic Mediodorsal Thalamus Activity Predicts and Reflects Longitudinal Treatment Outcomes in Psilocybin Therapy for Treatment-Resistant DepressionBiological Psychiatry · 2025-04-09 Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor.Journal of child and adolescent psychopharmacology · 2025-04-01 Less is more? A review of psilocybin microdosing.Journal of psychopharmacology (Oxford, England) · 2024-10-01 Safety pharmacology of acute psilocybin administration in healthy participants.Neuroscience applied · 2024-01-01 Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2023-10-01 Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.Translational psychiatry · 2022-08-11 Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2022-05-01 [Addictions].Revue medicale suisse · 2020-01-15 THE POTENTIAL THERAPEUTIC VALUE OF PSILOCYBIN: In Relation to DepressionDiva portal (Dalarna University Library) · 2018-12-31

Author directory